Apellis Pharmaceuticals, Inc. (APLS)
20.71
-0.25
(-1.19%)
USD |
NASDAQ |
Mar 02, 16:00
20.71
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Accounts Payable (Quarterly) : 56.80M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 31.00M |
| Amneal Pharmaceuticals, Inc. | 254.67M |
| Alnylam Pharmaceuticals, Inc. | 115.72M |
| BioMarin Pharmaceutical, Inc. | 312.77M |
| Amicus Therapeutics, Inc. | 28.63M |